The Global Blood Cancer Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2027 | DelveInsight
March 09, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 09, 2023 (GLOBE NEWSWIRE) -- The Global Blood Cancer Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2027 | DelveInsight The blood cancer...
Minimal Residual Disease Global Market Report 2023: Growing Investment For Research Presents Opportunities
February 21, 2023 05:38 ET
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, Solid Tumors, Others); By Test...
Companion Diagnostics Market Size to Hit USD 5,471.68 Million by 2030 at 11.90% CAGR – Report by Market Research Future (MRFR)
February 20, 2023 09:00 ET
|
Market Research Future
New York, USA, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Companion Diagnostics...
The Global Minimal Residual Disease Testing Market size is expected to reach $2.7 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period
January 25, 2023 11:43 ET
|
ReportLinker
New York, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Minimal Residual Disease Testing Market Size, Share & Industry Trends Analysis Report By...
Minimal Residual Disease Testing Global Market Report 2022: Rising Prevalence of Cancer and Hematological Malignancies Fuels Sector
December 26, 2022 06:23 ET
|
Research and Markets
Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals,...
The global minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0%
December 20, 2022 07:22 ET
|
ReportLinker
New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Minimal Residual Disease Testing Market by Technology, Application, End User & Region - Global...
Global Hemato Oncology Testing Market Report 2022 to 2027: Drug Diagnostics Co-Development Presents Opportunities
December 12, 2022 08:14 ET
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma...
Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Cancer Type, End User, and Region - Analysis and Forecast, 2022-2032
December 02, 2022 06:01 ET
|
ReportLinker
New York, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product,...
The global Hemato oncology testing market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022, at a CAGR of 14.2%
November 29, 2022 07:33 ET
|
ReportLinker
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hemato Oncology Testing Market by Product & Services, Cancer, Lymphoma, Technology, End User -...
Cancer Biomarkers Market Size & Share to Surpass $31.8 Bn by 2028 | Vantage Market Research
November 10, 2022 11:49 ET
|
Vantage Market Research
WASHINGTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global Cancer Biomarkers Market was valued at $12.1 Billion in 2021 and is expected to reach $31.8 Billion by 2028, registering a CAGR of 17.5%...